Diabetic retinopathy is a pathology that should not be underestimated. What is that? How does it manifest itself? Are there any risk factors to look out for? What are the possible complications in case of “neglect”?
With the arrival of the SARS Covid-19 epidemic, there has been a visible increase in waiting lists, not without consequences. Where are we today? Is there a recovery that can guarantee continuity of care for the sick? It is important that the patient remains hooked to the doctor who can help him to better live his illness and, above all, who can propose medical or surgical therapies, depending on the case and the different types of pathology. To support research in this field and to give support to patients, Retina Italia was born, the first reference association for people with retinal dystrophy, which creates a collaborative network that allows them to reach the highest levels of hospitality and assistance.
Let’s clarify by looking for an answer to the questions of the readers of Corriere Salute together with Prof. Francesco Maria Bandellopresident of the Retina Patients Association, Director of the Ophthalmology Clinic of the Vita-Salute University IRCCS San Raffaele Hospital Milan, to Dr. Enrico Borrelli – Ophthalmologist at San Raffaele Hospital and vice-president of YORIS (Young Ophthalmologists Retinal Imaging Society) and to Dr. Stela Vujosevic Researcher at the University of Milan, La Statale – Head of the Retina Medica Unit, IRCCS MultiMedica, Milan